Cited by 587SARS-CoV-2 and COVID-19 ResearchAnimal Virus Infections Studiesvaccines and immunoinformatics approaches

The DOI matches its Crossref record; 85 of the 85 references it cites were found in a registry or an index.

Unexpected Receptor Functional Mimicry Elucidates Activation of Coronavirus Fusion

Open access

Walls, Alexandra C., Xiong, Xiaoli, Park, Young-Jun, Tortorici, M. Alejandra, Snijder, Joost, Quispe, Joel, Cameroni, Elisabetta, Gopal, Robin, Dai, Mian, Lanzavecchia, Antonio, Zambon, Maria, Rey, Félix A., Corti, Davide, Veesler, David·2019·Cell

DOI 10.1016/j.cell.2018.12.028PMC PMC6751136

Open this paper in CoChat — free account Open PDF

Abstract

Recent outbreaks of severe acute respiratory syndrome and Middle East respiratory syndrome, along with the threat of a future coronavirus-mediated pandemic, underscore the importance of finding ways to combat these viruses. The trimeric spike transmembrane glycoprotein S mediates entry into host cells and is the major target of neutralizing antibodies. To understand the humoral immune response elicited upon natural infections with coronaviruses, we structurally characterized the SARS-CoV and MERS-CoV S glycoproteins in complex with neutralizing antibodies isolated from human survivors. Although the two antibodies studied blocked attachment to the host cell receptor, only the anti-SARS-CoV S antibody triggered fusogenic conformational changes via receptor functional mimicry. These results provide a structural framework for understanding coronavirus neutralization by human antibodies and shed light on activation of coronavirus membrane fusion, which takes place through a receptor-driven ratcheting mechanism.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.cell.2018.12.028

Cites

85 of 85 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

UCSF Chimera—A visualization system for exploratory research and analysis
Pettersen, E. F., Goddard, T. D., Huang, C. C., Couch, G. S., Greenblatt, D. M., Meng, E. C., & Ferrin, T. E. (2004) · Journal of Computational Chemistry · doi:10.1002/jcc.20084 · Cited by 45,882
Features and development of Coot
Emsley, P., Lohkamp, B., Scott, W. G., & Cowtan, K. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444910007493 · Cited by 29,915
PHENIX : a comprehensive Python-based system for macromolecular structure solution
Adams, P. D., Afonine, P. V., Bunkóczi, G., Chen, V. B., Davis, I. W., Echols, N., Headd, J. J., Hung, L.-W., Kapral, G. J., Grosse-Kunstleve, R. W., et al. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444909052925 · Cited by 23,716
XDS
Kabsch, W. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444909047337 · Cited by 16,463
MolProbity : all-atom structure validation for macromolecular crystallography
Chen, V. B., Arendall, W. B., Headd, J. J., Keedy, D. A., Immormino, R. M., Kapral, G. J., Murray, L. W., Richardson, J. S., & Richardson, D. C. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444909042073 · Cited by 14,115
cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination
Punjani, A., Rubinstein, J. L., Fleet, D. J., & Brubaker, M. A. (2017) · Nature Methods · doi:10.1038/nmeth.4169 · Cited by 11,626
Inference of Macromolecular Assemblies from Crystalline State
Krissinel, E., & Henrick, K. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.05.022 · Cited by 10,007
MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy
Zheng, S. Q., Palovcak, E. J., Armache, J., Verba, K. A., Cheng, Y., & Agard, D. A. (2017) · Nature Methods · doi:10.1038/nmeth.4193 · Cited by 7,496
PHENIX: a comprehensive Python-based system for macromolecular structure solution
Adams, P. D., Afonine, P. V., Bunkòczi, G., Chen, V. B., Davis, I., Echols, N., Headd, J. J., Hung, L., Kapral, G. J., Grosse‐Kunstleve, R. W., et al. (2012) · International Tables for Crystallography · doi:10.1107/97809553602060000865 · Cited by 7,334
Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus
Li, W., Moore, M. J., Vasilieva, N., Sui, J., Wong, S. K., Berne, M. A., Somasundaran, M., Sullivan, J. L., Luzuriaga, K., Greenough, T. C., et al. (2003) · Nature · doi:10.1038/nature02145 · Cited by 5,923

Flagged first, then by citations

Show all 85 references

Sorted by citations

Items 401–500 of 587

3D Models of glycosylated SARS-CoV-2 spike protein suggest challenges and opportunities for vaccine development
Grant, O. C. (2021) · ModelArchive SIB · doi:10.5452/ma-zykoq · Cited by 16
Origin of SARS-CoV-2
Çakal, B. (2020) · Turkiye Klinikleri Journal of Medical Ethics-Law and History · doi:10.5336/mdethic.2020-76286 · Cited by 10
Isolation and escape mapping of broadly neutralizing antibodies against emerging delta-coronaviruses
Rexhepaj, M., Asarnow, D. E., Perruzza, L., Park, Y., Guarino, B., Mccallum, M., Culap, K., Saliba, C., Leoni, G., Balmelli, A., et al. (2024) · Immunity · doi:10.1016/j.immuni.2024.10.001 · Cited by 10
Self-citation
Progress in Studies on Structural and Remedial Aspects of Newly Born Coronavirus, SARS-CoV-2
Gupta, S. P. (2020) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026620666200922112300 · Cited by 10
A key F27I substitution within HCDR1 facilitates the rapid maturation of P2C-1F11-like neutralizing antibodies in a SARS-CoV-2-infected donor
Wang, M., Fan, Q., Zhou, B., Ye, H., Shen, S., Yu, J., Cheng, L., Ge, X., Ju, B., & Zhang, Z. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111335 · Cited by 9
Single domain antibodies derived from ancient animals as broadly neutralizing agents for SARS-CoV-2 and other coronaviruses
Lim, H. T., Kok, B. H., Lim, C. P., Majeed, A. B. A., Leow, C. Y., & Leow, C. Y. (2022) · Biomedical Engineering Advances · doi:10.1016/j.bea.2022.100054 · Cited by 10
Lectin Fingerprinting Distinguishes Antibody Neutralization in SARS-CoV-2
Wuo, M. G., Dugan, A. E., Halim, M., Hauser, B. M., Feldman, J. E., Caradonna, T. M., Zhang, S., Pepi, L. E., Atyeo, C. G., Fischinger, S., et al. (2023) · ACS Central Science · doi:10.1021/acscentsci.2c01471 · Cited by 10
Potential SARS-CoV-2 Preimmune IgM Epitopes
Shivarov, V. S., Petrov, P. K., & Pashov, A. D. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00932 · Cited by 10
Dental workers in front-line of COVID-19: an in silico evaluation targeting their prevention
Sette‐de‐Souza, P. H., Costa, M. J. F., Amaral-Machado, L., Araújo, F. A. D. C., FILHO, A. T. A., & de Lima, L. R. A. (2021) · Journal of Applied Oral Science · doi:10.1590/1678-7757-2020-0678 · Cited by 10
Tackling Covid‐19 using disordered‐to‐order transition of residues in the spike protein upon angiotensin‐converting enzyme 2 binding
Yesudhas, D., Srivastava, A., Sekijima, M., & Gromiha, M. M. (2021) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.26088 · Cited by 9
Current Overviews on COVID-19 Management Strategies
Rai, P. K., Mueed, Z., Chowdhury, A., Deval, R., Kumar, D., Kamal, M. A., Negi, Y. S., Pareek, S., Sharma, H., & Poddar, N. K. (2021) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201022666210509022313 · Cited by 10
Full-Length Computational Model of the SARS-CoV-2 Spike Protein and Its Implications for a Viral Membrane Fusion Mechanism
Nishima, W., & Kulik, M. (2021) · Viruses · doi:10.3390/v13061126 · Cited by 10
Representing and Comparing Site-Specific Glycan Abundance Distributions of Glycoproteins
Remoroza, C. A., Burke, M. C., Liu, Y., Mirokhin, Y. A., Tchekhovskoi, D. V., Yang, X., & Stein, S. E. (2021) · Journal of Proteome Research · doi:10.1021/acs.jproteome.1c00442 · Cited by 10
Clinical drug therapies and biologicals currently used or in clinical trial to treat COVID-19
Malek, R. J., Bill, C. A., & Vines, C. M. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112276 · Cited by 10
Impact of temperature on the affinity of SARS-CoV-2 Spike for ACE2Preprint
Prévost, J., Richard, J., Gasser, R., Ding, S., Fage, C., Anand, S. P., Adam, D., Vergara, N. G., Tauzin, A., Benlarbi, M., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.07.09.451812 · Cited by 10
Presence of antibodies against SARS-CoV-2 spike protein in bovine whey IgG enriched fraction
Oshiro, S., Tada, T., Mizutani, N., Funatogawa, K., Sekiguchi, J., Takahashi, M., & Kirikae, T. (2021) · International Dairy Journal · doi:10.1016/j.idairyj.2021.105002 · Cited by 9
Targeting SARS‐CoV‐2 RBD Interface: a Supervised Computational Data‐Driven Approach to Identify Potential Modulators
Gulotta, M. R., Lombino, J., Perricone, U., Simone, G. D., Mekni, N., Rosa, M. D., Diana, P., & Padova, A. (2020) · ChemMedChem · doi:10.1002/cmdc.202000259 · Cited by 7
Structure and Immune Recognition of the Porcine Epidemic Diarrhea Virus Spike Protein
Kirchdoerfer, R. N., Bhandari, M., Martini, O., Sewall, L. M., Bangaru, S., Yoon, K.-J., & Ward, A. B. (2020) · Microscopy and Microanalysis · doi:10.1017/s1431927620021923 · Cited by 10
Structural basis of Omicron immune evasion: A comparative computational study
Contractor, D., Globisch, C., Swaroop, S., & Jain, A. K. (2022) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2022.105758 · Cited by 10
Proteomics‐based mass spectrometry profiling of SARS‐CoV‐2 infection from human nasopharyngeal samples
Chatterjee, S., & Zaia, J. (2022) · Mass spectrometry reviews (Print) · doi:10.1002/mas.21813 · Cited by 7
Molecular Evolution of SARS-CoV-2 Structural Genes: Evidence of Positive Selection in the Spike GlycoproteinPreprint
Zhan, X.-Y., Zhang, Y., Zhou, X., Huang, K., Qian, Y., Leng, Y., Yan, L., Huang, B., & He, Y. (2020) · doi:10.21203/rs.3.rs-42498/v2 · Cited by 9
Millisecond-scale molecular dynamics simulation of spike RBD structure reveals evolutionary adaption of SARS-CoV-2 to stably bind ACE2Preprint
Nelson, G., Buzko, O. V., Bassett, A., Spilman, P., Niazi, K., Rabizadeh, S., & Soon‐Shiong, P. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.12.11.422055 · Cited by 9
Spike mutations that affect the function and antigenicity of recent KP.3.1.1-like SARS-CoV-2 variants
Dadonaite, B., Harari, S., Larsen, B. B., Kampman, L., Harteloo, A., Elias-Warren, A., Chu, H. Y., & Bloom, J. D. (2025) · Journal of Virology · doi:10.1128/jvi.01423-25 · Cited by 11
An outlook on potential protein targets of COVID-19 as a druggable site
Noori, R., & Sardar, M. (2022) · Molecular Biology Reports · doi:10.1007/s11033-022-07724-3 · Cited by 9
Cryoelectron microscopy structures of a human neutralizing antibody bound to MERS-CoV spike glycoprotein
Zhang, S., Jia, W., Zeng, J., Li, M., Wang, Z., Zhou, H., Zhang, L., & Wang, X. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.988298 · Cited by 8
Bioinformatic prediction of immunodominant regions in spike protein for early diagnosis of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Zhuang, S., Tang, L., Dai, Y., Feng, X., Fang, Y., Tang, H., Jiang, P., Wu, X. F., Fang, H., & Chen, H. (2021) · PeerJ · doi:10.7717/peerj.11232 · Cited by 8
A theranostic approach based on radiolabeled antiviral drugs, antibodies and CRISPR-associated proteins for early detection and treatment of SARS-CoV-2 disease
Shiri, I., Abdollahi, H., Atashzar, M. R., Rahmim, A., & Zaidi, H. (2020) · Nuclear Medicine Communications · doi:10.1097/mnm.0000000000001269 · Cited by 8
Blocking antibodies against SARS-CoV-2 RBD isolated from a phage display antibody library using a competitive biopanning strategyPreprint
Zeng, X. W., Li, L., Lin, J., Li, X., Liu, B., Kong, Y., Zeng, S., Du, J., Xiao, H., Zhang, T., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.04.19.049643 · Cited by 8
Generalizing a Ligation Site at the N-Glycosylation Sequon for Chemical Synthesis of N-Linked Glycopeptides and Glycoproteins
Li, D., Li, C., Chen, Q., Zhou, H., Zhong, Z., Huang, Z., Liu, H., & Li, X. (2024) · Journal of the American Chemical Society · doi:10.1021/jacs.4c09996 · Cited by 7
Natural flavonoid pectolinarin computationally targeted as a promising drug candidate against SARS-CoV-2
Rani, M., Sharma, A. K., Chouhan, R., Sur, S., Mansuri, R., & Singh, R. (2023) · Current Research in Structural Biology · doi:10.1016/j.crstbi.2023.100120 · Cited by 6
Clinical efficacy of anti‐SARS‐CoV‐2 monoclonal antibodies in preventing hospitalisation and mortality among patients infected with Omicron variants: A systematic review and meta‐analysis
Miljanovic, D., Cirkovic, A. M., Lazarević, I., Knežević, A., Cupic, M. D., & Banko, A. V. (2023) · Reviews in Medical Virology · doi:10.1002/rmv.2439 · Cited by 9
Understanding the role of conserved proline and serine residues in the SARS-CoV-2 spike cleavage sites in the virus entry, fusion, and infectivity
Khatri, R., Lohiya, B., Kaur, G., Maithil, V., Goswami, A., Sarmadhikari, D., Asthana, S., & Samal, S. (2023) · 3 Biotech · doi:10.1007/s13205-023-03749-y · Cited by 7
Dissecting the Heterogeneous Glycan Profiles of Recombinant Coronavirus Spike Proteins with Individual Ion Mass Spectrometry
Stiving, A. Q., Foreman, D. J., VanAernum, Z. L., Dürr, E., Wang, S., Vlasak, J., Galli, J. D., Kafader, J. O., Tsukidate, T., Li, X., et al. (2023) · Journal of the American Society for Mass Spectrometry · doi:10.1021/jasms.3c00309 · Cited by 8
Identification of a SARS-like bat coronavirus that shares structural features with the spike glycoprotein receptor-binding domain of SARS-CoV-2
Bringas, C. F., & Booth, D. B. (2020) · Access Microbiology · doi:10.1099/acmi.0.000166 · Cited by 7
Coronavirus Disease 2019: A Brief Review of the Clinical Manifestations and Pathogenesis to the Novel Management Approaches and Treatments
Kooshkaki, O., Derakhshani, A., Conradie, A. M., Hemmat, N., Barreto, S. G., Baghbanzadeh, A., Singh, P. K., Safarpour, H., Asadzadeh, Z., Najafi, S., et al. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.572329 · Cited by 7
Allelic Variants Within the ABO Blood Group Phenotype Confer Protection Against Critical COVID-19 Hospital Presentation
Jelinek, H. F., Mousa, M., Kaabi, N. A. M. A., Alefishat, E. A., Elbait, G. D., Kannout, H., Alhumaidan, H., Selvaraj, F. A., Imambaccus, H., Weber, S., et al. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2021.759648 · Cited by 7
Closing coronavirus spike glycoproteins by structure-guided designPreprint
McCallum, M., Walls, A. C., Corti, D., & Veesler, D. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.06.03.129817 · Cited by 7
Self-citation
Delta breakthrough infections elicit potent, broad and durable neutralizing antibody responsesPreprint
Walls, A. C., Sprouse, K. R., Joshi, A., Bowen, J. E., Franko, N., Navarro, M. J., Stewart, C., McCallum, M., Goecker, E. A., Degli-Angeli, E., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.12.08.471707 · Cited by 8
Self-citation
Ultrapotent SARS coronavirus-neutralizing single-domain antibodies that bind a conserved membrane proximal epitope of the spikePreprint
Cae, S. D., Molle, I. V., van Schie, L., Shoemaker, S. R., Deckers, J., Debeuf, N., Lameire, S., Nerinckx, W., Roose, K., Fijałkowska, D., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.03.10.531533 · Cited by 7
Angiotensin-Converting Enzyme-2 (ACE2) Downregulation During Coronavirus Infection
Rashid, N. N., Amrani, L., Alwan, A., Mohamed, Z., Yusof, R., & Rothan, H. A. (2024) · Molecular Biotechnology · doi:10.1007/s12033-024-01277-5 · Cited by 6
A stabilized MERS-CoV spike ferritin nanoparticle vaccine elicits robust and protective neutralizing antibody responses
Powell, A. E., Caruso, H., Park, S., Chen, J., O’Rear, J., Ferrer, B., Stieh, D. J., Weiss, A. M., Belnap, D. M., Walker, A. E., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-68458-5 · Cited by 6
Self-citation
Conserved High Free Energy Sites in Human Coronavirus Spike Glycoprotein Backbones
Penner, R. (2020) · Journal of Computational Biology · doi:10.1089/cmb.2020.0193 · Cited by 6
Magainin as an Antiviral Peptide of SARS-CoV-2 Main Protease for Potential Inhibitor: An In Silico Approach
Fakih, T. M., Dewi, M. L., & Syahroni, E. (2020) · Biogenesis Jurnal Ilmiah Biologi · doi:10.24252/bio.v8i1.13871 · Cited by 6
Will Peptides Help to Stop COVID-19?
Krut’, V. G., Chuvpilo, S. A., Astrakhantseva, I. V., Kozlovskaya, L. I., Efimov, G. A., Kruglov, A., Drutskaya, M. S., & Nedospasov, S. A. (2022) · Biochemistry (Moscow) · doi:10.1134/s0006297922070021 · Cited by 7
Development of a Multiepitope Vaccine Against SARS-CoV-2: Immunoinformatics Study
Ghafouri, F., Cohan, R. A., Samimi, H., Rad, S. M. A. H., Naderi, M., Noorbakhsh, F., & Haghpanah, V. (2022) · JMIR Bioinformatics and Biotechnology · doi:10.2196/36100 · Cited by 6
Therapeutic and Vaccine Options for COVID-19: Status after Six Months of the Disease Outbreak
Maciorowski, D., Ogaugwu, C., Durvasula, S. R., Durvasula, R. V., & Kunamneni, A. (2020) · SLAS DISCOVERY · doi:10.1177/2472555220979579 · Cited by 6
SARS-CoV-2 and other human coronaviruses: Mapping of protease recognition sites, antigenic variation of spike protein and their grouping through molecular phylogenetics
Chakraborty, C., Sharma, A. R., Bhattacharya, M., Saha, R. P., Ghosh, S., Biswas, S., Samanta, S., Sharma, G., Agoramoorthy, G., & Lee, S. (2021) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2021.104729 · Cited by 6
Synthetic proteins for COVID-19 diagnostics
Schein, C. H., Levine, C. B., McLellan, S., Negi, S. S., Braun, W. A., Dreskin, S. C., Anaya, E. S., & Schmidt, J. G. (2021) · Peptides · doi:10.1016/j.peptides.2021.170583 · Cited by 6
Use of Isoelectric Point for Fast Identification of Anti-SARS CoV-2 Coronavirus ProteinsPreprint
Mallik, K. (2020) · Preprints.org · doi:10.20944/preprints202005.0270.v1 · Cited by 6
Differential Dynamic Behavior of Prefusion Spike Proteins of SARS Coronaviruses 1 and 2Preprint
Kumar, V. G., Ogden, D. S., Isu, U. H., Polasa, A., Losey, J., & Moradi, M. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.12.25.424008 · Cited by 7
Molecular Evolution of SARS-CoV-2 Structural Genes: Evidence of Positive Selection in Spike GlycoproteinPreprint
Zhan, X.-Y., Zhang, Y., Zhou, X., Huang, K., Qian, Y., Leng, Y., Yan, L., Huang, B., & He, Y. (2020) · doi:10.21203/rs.3.rs-42498/v1 · Cited by 6
ACE2 utilization of HKU25 clade MERS-related coronaviruses with broad geographic distributionPreprint
Liu, C., Park, Y., Ma, C., Stuart, C., Gen, R., Sun, Y., Yang, X. Y., Lin, M. C., Xiong, Q., Si, J.-Y., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.02.19.639017 · Cited by 6
Self-citation
Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology
Piccoli, L., Park, Y.-J., Tortorici, M. A., Czudnochowski, N., Walls, A. C., Beltramello, M., Silacci-Fregni, C., Pinto, D., Rosen, L. E., Bowen, J. E., et al. (2020) · Cell · doi:10.1016/j.cell.2020.09.037 · Cited by 1,395
Self-citation
Analysis of Protein Glycosylation after Rapid Digestion Using Protease-Containing Membranes in Spin Columns
Cao, W., & Bruening, M. L. (2023) · Journal of the American Society for Mass Spectrometry · doi:10.1021/jasms.3c00038 · Cited by 5
Human coronavirus OC43 nanobody neutralizes virus and protects mice from infection
Adair, A., Tan, L. L., Feng, J., Girkin, J. L. N., Bryant, N., Wang, M., Mordant, F. L., Chan, L., Bartlett, N. W., Subbarao, K., et al. (2024) · Journal of Virology · doi:10.1128/jvi.00531-24 · Cited by 5
Structural characterization of human monoclonal antibodies targeting uncommon antigenic sites on spike glycoprotein of SARS-CoV
Suryadevara, N., Kose, N., Bangaru, S., Binshtein, E., Munt, J. E., Martinez, D. R., Schäfer, A., Myers, L., Scobey, T., Carnahan, R. H., et al. (2024) · Journal of Clinical Investigation · doi:10.1172/jci178880 · Cited by 6
Structural Studies of Coronavirus Fusion Proteins
Walls, A. C., Tortorici, M. A., Xiong, X., Snijder, J., Frenz, B., Bosch, B., DiMaio, F., Corti, D., Rey, F. A., & Veesler, D. (2019) · Microscopy and Microanalysis · doi:10.1017/s1431927619007232 · Cited by 5
Self-citation
New perspective towards therapeutic regimen against SARS-CoV-2 infection
Srivastava, V., & Ahmad, A. (2021) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2021.05.009 · Cited by 5
Language model-accelerated deep symbolic optimization
da Silva, F. L., Gonçalves, A. R., Nguyen, S., Vashchenko, D., Glatt, R., Desautels, T., Landajuela, M., Faissol, D., & Petersen, B. K. (2023) · Neural Computing and Applications · doi:10.1007/s00521-023-08802-8 · Cited by 5
Dynamics of water-mediated interaction effects on the stability and transmission of Omicron
Zaman, N., Parvaiz, N., Gul, F., Yousaf, R., Gul, K., & Azam, S. S. (2023) · Scientific Reports · doi:10.1038/s41598-023-48186-2 · Cited by 5
Sequence of the SARS-CoV-2 Spike Transmembrane Domain Encodes Conformational Dynamics
Lall, S., Balaram, P., Mathew, M. K., & Gosavi, S. (2024) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.4c05270 · Cited by 5
Increased Pathogenicity and Virulence of Middle East Respiratory Syndrome Coronavirus Clade B In Vitro and In Vivo
Wang, Y., Sun, J., Li, X., Zhu, A., Guan, W., Sun, D.-Q., Gan, M., Niu, X., Dai, J., Zhang, L., et al. (2020) · Journal of Virology · doi:10.1128/jvi.00861-20 · Cited by 5
Development of Coronavirus Treatments Using Neutralizing Antibodies
Fouladirad, S., & Bach, H. (2021) · Microorganisms · doi:10.3390/microorganisms9010165 · Cited by 5
Rapid label‐free detection of Salmonella enterica with biolayer interferometry
Zang, C., Zhang, M., Zhang, Y., Li, Y., Liu, K., Xie, N., Sun, C., & Zhang, X. (2021) · Journal of Food Safety · doi:10.1111/jfs.12896 · Cited by 5
Dimethoxycurcumin Acidifies Endolysosomes and Inhibits SARS-CoV-2 Entry
Khan, N., Afghah, Z., Baral, A., Geiger, J. D., & Chen, X. (2022) · Frontiers in Virology · doi:10.3389/fviro.2022.923018 · Cited by 5
Structure adaptation in Omicron SARS-CoV-2/hACE2: Biophysical origins of evolutionary driving forces
Hsiao, Y., Bray, D. J., Taddese, T., Jiménez-Serratos, G., & Crain, J. N. (2023) · Biophysical Journal · doi:10.1016/j.bpj.2023.09.003 · Cited by 5
México con mayor riesgo ante el COVID-19, factores de riesgo que pueden aumentar la ECA2
Vique‐Sánchez, J. L., & Galindo‐Hernández, O. (2021) · Nutrición clínica y dietética hospitalaria/Nutrición clínica, dietética hospitalaria · doi:10.12873/411vique · Cited by 5
A bispecific monomeric nanobody induces spike trimer dimers and neutralizes SARS-CoV-2 in vivoPreprint
Hanke, L., Das, H., Sheward, D. J., Vidakovics, L. P., Urgard, E., Moliner-Morro, A., Kim, C., Karl, V., Pankow, A. P., Smith, N. L., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.03.20.436243 · Cited by 5
Diversity of Coronavirus ReceptorsPreprint
Ghosh, P., Jayaram, S., Patwardhan, D., Marimuthu, S., Lenehan, P. J., Venkatakrishnan, A., Hughes, T. K., Zemmour, D., Anand, P., & Soundararajan, V. (2021) · Preprints.org · doi:10.20944/preprints202108.0071.v1 · Cited by 4
Single-molecule imaging prefusion intermediate conformations of MERS-CoV spike trimers in membrane during entry
Dey, S., Pahari, P., Shukla, M., Andrabi, R., & Das, D. K. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.115916 · Cited by 4
Receptor affinity-selective differential dynamics of membrane fusion initiation govern deltacoronavirus cross-species transmission
An, D., Peng, Q., Ma, Y., Hong, W., Pei, Y., Liu, S., Li, Y., Li, J., Shan, Y., Yin, Y., et al. (2025) · Science China Life Sciences · doi:10.1007/s11427-025-2985-1 · Cited by 4
TMPRSS2-mediated coronavirus spike activation and inhibition
McCallum, M., Case, J. B., Brown, J. T., Park, Y., Lee, J., Sutherland, E., Aggarwal, A., Gibson, C. A., Lempp, F. A., Stewart, C., et al. (2026) · Nature Structural & Molecular Biology · doi:10.1038/s41594-026-01801-y · Cited by 5
Self-citation
Rarely Recognized Antibody Diversification in Covid-19 Evolution to Counteract Advanced SARS-CoV-2 Evasion Strategies, and Implications for Prophylactic Treatment
Mueller, S. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.624675 · Cited by 4
Complete genome sequencing of SARS-CoV-2 strains: A pilot survey in Palestine reveals spike mutation H245N
Al‐Jawabreh, A., Ereqat, S., Dumaidi, K., Al-Jawabreh, H., & Nasereddin, A. (2021) · BMC Research Notes · doi:10.1186/s13104-021-05874-4 · Cited by 4
Gut distress and intervention via communications of SARS-CoV-2 with mucosal exposome
Moon, Y. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1098774 · Cited by 4
SARS‐CoV‐2 neutralising antibody therapies: Recent advances and future challenges
Liu, M., Liang, Z., Cheng, Z. J., Liu, L., Liu, Q., Mai, Y., Chen, H., Lei, B., Yu, S., Chen, H., et al. (2023) · Reviews in Medical Virology · doi:10.1002/rmv.2464 · Cited by 4
Characterization and immunogenicity assessment of MERS-CoV pre-fusion spike trimeric oligomers as vaccine immunogen
Ahuja, R., Vishwakarma, P., Raj, S., Kumar, V., Khatri, R., Lohiya, B., Saxena, S., Kaur, G., Singh, G., Asthana, S., et al. (2024) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2024.2351664 · Cited by 4
Hexamerization of Anti-SARS CoV IgG1 Antibodies Improves Neutralization Capacity
Pande, K., Hollingsworth, S. A., Sam, M., Gao, Q., Singh, S., Saha, A., Vroom, K., Shirley, X., Brazell, T., Gorman, D., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.864775 · Cited by 5
Nigella sativa and its chemical constituents: pre-clinical and clinical evidence for their potential anti-SARS-CoV-2 effects
Cyril, A. C., Ali, N. N. A., Parambath, A. N., Vazhappilly, C. G., Jan, R. K., Karuvantevida, N. S., Aburamadan, H., Lozon, Y., & Radhakrishnan, R. (2023) · Inflammopharmacology · doi:10.1007/s10787-023-01385-9 · Cited by 4
Alimentary system is directly attacked by SARS‐COV‐2 and further prevents immune dysregulation caused by COVID‐19
Chen, S., Zhou, J., Ou, X., Cheng, W., Qin, Y., Guo, Y., & Jiang, Y. (2020) · International Journal of Clinical Practice · doi:10.1111/ijcp.13893 · Cited by 5
Neutralizing monoclonal antibodies against highly pathogenic coronaviruses
Xiang, R., Wang, Y., Wang, L., Deng, X., Huo, S., Jiang, S., & Yu, F. (2021) · Current Opinion in Virology · doi:10.1016/j.coviro.2021.12.015 · Cited by 4
Prefusion spike protein stabilization through computational mutagenesis
Zhang, D. Y., Wang, J., & Dokholyan, N. V. (2020) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.26025 · Cited by 3
Mapping active allosteric loci SARS-CoV Spike Proteins by means of Protein Contact NetworksPreprint
Paola, L. D., & Giuliani, A. (2020) · Zenodo (CERN European Organization for Nuclear Research) · doi:10.5281/zenodo.3776149 · Cited by 4
Receptor binding may directly activate the fusion machinery in coronavirus spike glycoproteinsPreprint
Wang, Y., Fallon, L., Raguette, L. E., Budhan, S., Belfon, K. A. A., Stepanenko, D., Helbock, S., Varghese, S., & Simmerling, C. L. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.05.10.443496 · Cited by 4
Conformational dynamics and allosteric modulation of the SARS-CoV-2 spikePreprint
Díaz-Salinas, M. A., Li, Q., Ejemel, M., Yurkovetskiy, L., Luban, J., Shen, K., Wang, Y., & Munro, J. B. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.10.29.466470 · Cited by 4
Human neutralizing antibodies to cold linear epitopes and to subdomain 1 of SARS-CoV-2Preprint
Bianchini, F., Crivelli, V., Abernathy, M. E., Guerra, C., Palus, M., Muri, J., Marcotte, H., Piralla, A., Pedotti, M., Gasparo, R. D., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.11.24.515932 · Cited by 4
Potential use of endemic human coronaviruses to stimulate immunity against pathogenic SARS-CoV-2 and its variants
Shamabadi, N. S., Bagasra, A. B., Pawar, S., & Bagasra, O. (2023) · Libyan Journal of Medicine · doi:10.1080/19932820.2023.2209949 · Cited by 3
Understanding the SARS-CoV-2 Virus Neutralizing Antibody Response: Lessons to Be Learned from HIV and Respiratory Syncytial Virus
Dimmock, N. J., & Easton, A. J. (2023) · Viruses · doi:10.3390/v15020504 · Cited by 3
Inhalable Nanofitin demonstrates high neutralization of SARS-CoV-2 virus via direct application in respiratory tract
Viollet, S., Enouf, E., Picot, J., Noël, L., Huet, S., Pennec, D. L., Sécher, T., Heuzé‐Vourc'h, N., Kitten, O., & Cinier, M. (2023) · Molecular Therapy · doi:10.1016/j.ymthe.2023.08.010 · Cited by 4
Analysis of how antigen mutations disrupt antibody binding interactions toward enabling rapid and reliable antibody repurposing
Islam, S., Chauhan, V. M., & Pantazes, R. J. (2024) · mAbs · doi:10.1080/19420862.2024.2440586 · Cited by 4
Drug Weaponry to Fight Against SARS-CoV-2
Cabezón, E., & Aréchaga, I. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.00204 · Cited by 3
Imunologia da Doença por Coronavírus-19 (COVID-19): Uma Perspetiva Para o Clínico, nos Primeiros 4 Meses da Emergência do SARS-CoV-2
Delgado, L., Boechat, J. L., & Chora, I. (2021) · Medicina Interna · doi:10.24950/rspmi/covid19/fmup/s/2020 · Cited by 3
A Recent Update on Therapeutics to Treat Emerging n-COVID 19: A Review
Ashique, S., Sandhu, N. K., Haque, S. N., & Koley, K. (2020) · Coronaviruses · doi:10.2174/2666796701999201204123259 · Cited by 3
Computational Study of Scorpion Venom (Lychas Mucronatus) Activity as Antimicrobial Peptides (AMPs) to the SARS-CoV-2 Main Protease for the Future Coronavirus Disease (COVID-19) Inhibitors
Fakih, T. M. (2021) · Molekul · doi:10.20884/1.jm.2021.16.2.715 · Cited by 3
Double Lock of a Potent Human Monoclonal Antibody against SARS-CoV-2Preprint
Zhu, L., Deng, Y., Zhang, R., Cui, Z., Sun, C., Fan, C., Xing, X., Huang, W., Chen, Q., Zhang, N., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.11.24.393629 · Cited by 3
Deep mining of early antibody response in COVID-19 patients yields potent neutralisers and reveals high level of convergencePreprint
Bullen, G., Galson, J., Villar, P., Moreels, L., Ledsgaard, L., Mattiuzzo, G., Hall, G., Bentley, E., Masters, E. W., Tang, D. M., et al. (2020) · bioRxiv · doi:10.1101/2020.12.29.424711 · Cited by 4
Computational study of the strong binding mechanism of SARS-CoV-2 spike and ACE2Preprint
Peng, C., Zhu, Z., Shi, Y., Wang, X., Mu, K., Yang, Y., Zhang, X., Xu, Z., & Zhu, W. (2020) · ChemRxiv · doi:10.26434/chemrxiv.11877492 · Cited by 3
A broadly generalizable stabilization strategy for sarbecovirus fusion machinery vaccinesPreprint
Lee, J., Stewart, C., Schaefer, A., Leaf, E. M., Park, Y., Asarnow, D. E., Powers, J. M., Treichel, C., Corti, D., Baric, R. S., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.12.12.571160 · Cited by 3
Self-citation
AI recognizes convergent somatic hypermutation signatures to allow the discovery of variant-resilient broadly neutralizing antibodiesPreprint
Yan, Q., Huang, X., Liu, B., Yao, Y., Zheng, H., Song, Y., Wu, F., He, Z., Li, S., Chen, F., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2025.12.10.693372 · Cited by 3
Self-citation
Hydrogen–Deuterium Exchange Mass Spectrometry Reveals an Antibody-Induced Allosteric Pathway Driving SARS-CoV-2 Spike Trimer Disassembly
Luo, Y., Liu, B., Liu, R., Chen, Q., Xiong, X., & Li, H. (2026) · Journal of the American Chemical Society · doi:10.1021/jacs.5c18784 · Cited by 3
Self-citation

Authors: Walls, A. C., Xiong, X., Park, Y.-J., Tortorici, M. A., Snijder, J., Quispe, J., Cameroni, E., Gopal, R., Dai, M., Lanzavecchia, A., Zambon, M., Rey, F. A., Corti, D., & Veesler, D.
Affiliations: University of Washington (US)
Centre National de la Recherche Scientifique (FR)
Vir Biotechnology (Switzerland) (CH)
Public Health England (GB)
The Francis Crick Institute (GB)
Institute for Research in Biomedicine (CH)
Corresponding author: Veesler, David
ORCID: Walls, Alexandra C.
Xiong, Xiaoli
Park, Young-Jun
Tortorici, M. Alejandra
Snijder, Joost
Quispe, Joel
Cameroni, Elisabetta
Lanzavecchia, Antonio
Zambon, Maria
Corti, Davide
Veesler, David
Venue: Cell
Publisher: Elsevier BV
Published: 2019-02
Volume: 176
Issue: 5
Pages: 1026-1039.e15
ISSN: 0092-8674 (ISSN-L)
DOI: 10.1016/j.cell.2018.12.028
PMC: PMC6751136
OpenAlex: W2915009278
Cited by: 582
References: 85
Citations by year: 2026: 7 · 2025: 25 · 2024: 30 · 2023: 40 · 2022: 79 · 2021: 173 · 2020: 214 · 2019: 14
FWCI: 92.33
Type: journal article
Language: en
Update notices: erratum (2020-12-10)
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
www.elsevier.com/open-access/userlicense/1.0/ (vor, 385 d)
Locations: Cell (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
HAL (submittedVersion)
Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
Funders: National Institute of General Medical Sciences (R01GM120553)
National Institute of Allergy and Infectious Diseases (HHSN272201700059C)
Pew Biomedical Scholars Award
Burroughs Wellcome Fund
Netherlands Organisation for Scientific Research (Rubicon 019.2015.2.310.006)
European Molecular Biology Organization (ALTF933-2015)
Zoonoses Anticipation and Preparedness Initiative (IMI115760)
Pasteur Institute
Centre National de la Recherche Scientifique
LabEx Integrative Biology of Emerging Infectious Diseases
University of Washington Arnold and Mabel Beckman CryoEM Center and Proteomics Resource (UWPR95794)
Advanced Light Source at Lawrence Berkley National Laboratory
Topics: Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
Life Sciences › Agricultural and Biological Sciences › Animal Science and Zoology › Animal Virus Infections Studies
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › vaccines and immunoinformatics approaches
Keywords: SARS-CoV, MERS-CoV, neutralizing antibodies, antibody-antigen complex structure, humoral immune response, viral entry, receptor binding
MeSH terms: Animals, Antibodies, Monoclonal, Antibodies, Viral, Chlorocebus aethiops, Humans, Protein Binding, Receptors, Virus, Vero Cells, Coronavirus, Coronavirus Infections, Molecular Mimicry, Severe acute respiratory syndrome-related coronavirus, Virus Internalization, Immunity, Humoral, Antibodies, Neutralizing, HEK293 Cells, Spike Glycoprotein, Coronavirus, Middle East Respiratory Syndrome Coronavirus

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Unexpected Receptor Functional Mimicry Elucidates Activation of Coronavirus Fusion

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks